Atlas Trials

Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma

Clinical trial NCT00813449 · UNKNOWN

Trial details

NCT number
NCT00813449
Sponsor
Simcere Pharmaceutical Co., Ltd
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced MelanomaUntreated Patients
Start date
2008-08-01
Primary completion
2010-08-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.